Lymphadenectomy for Gastric Cancer
- 15 July 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (14), 2759-2761
- https://doi.org/10.1200/jco.2004.02.995
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501Journal of Clinical Oncology, 2004
- Surgeon Volume and Operative Mortality in the United StatesNew England Journal of Medicine, 2003
- Extended Local Resection for Advanced Gastric CancerAnnals of Surgery, 2002
- Hospital Volume and Surgical Mortality in the United StatesNew England Journal of Medicine, 2002
- Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer.Annals of Surgical Oncology, 2002
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- Extended Lymph-Node Dissection for Gastric CancerNew England Journal of Medicine, 1999
- Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trialBritish Journal of Cancer, 1999
- Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patientsThe Lancet, 1995
- New method to evaluate the therapeutic value of lymph node dissection for gastric cancerBritish Journal of Surgery, 1995